While the precise identity and localization of the signal remain uncertain, B lymphocytes are known to be permissive to productive SARS-CoV-2 infection (39), and NRP1 expression provides a potential mechanism for the severe lymphopenia associated with poor outcomes in COVID-19 patients (40). Here, NRP1 is linked to lymphopenia.